Back to Capital Research Global Investors Capital Research Global Investors

GILDGILD
Showing 8 of 31 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in GILEAD SCIENCES INC

Yes. Capital Research Global Investors holds 19,393,296 shares of GILD (Gilead Sciences), worth $2.5B, as of its Q2 2026 13F filing. It reduced the position by 7,734,237 shares (-28.5%) from Q1 2026. Capital Research Global Investors has held GILD in every 13F on record since Q4 2018, 31 quarterly filings. GILD is 0.3% of Capital Research Global Investors' reported 13F portfolio.

Current Value

$2.5B

Current Shares

19.4M

Total Value Change

-$2.7B

Total Shares Change

-42.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
19.4M
-28.5%
$2.5B0.3%$125.63
0
2026-Q1
Increased
27.1M
+7.2%
$3.8B0.6%$137.68
48
2025-Q4
Decreased
25.3M
-15.7%
$3.1B0.6%$120.57
0
2025-Q3
Decreased
30M
-3.5%
$3.3B0.6%$108.32
0
2025-Q2
Decreased
31.1M
-43.1%
$3.4B0.7%$107.45
0
2025-Q1
Decreased
54.6M
-5.8%
$6.1B1.3%$107.83
0
2024-Q4
Decreased
57.9M
-6.2%
$5.4B1.1%$88.27
0
2024-Q3
Increased
61.8M
+2.3%
$5.2B1.1%$79.45
51

Other major holders of GILD: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used